Your Followed Topics

Top 2 american cancer society News Today

#1
Blood test added to colorectal cancer screening options by cancer group
#1 out of 219.96%
health3h ago

Blood test added to colorectal cancer screening options by cancer group

https://www.nbcnews.com/health/health-news/blood-test-added-colorectal-cancer-screening-options-cancer-group-rcna346902https://www.cnn.com/2026/05/27/health/blood-test-colorectal-cancer-screening-wellness
Nbcnews.com and 1 more
  • The American Cancer Society added Guardant Health's Shield blood test to its recommended colorectal cancer screening options.
  • The Shield test is not meant to replace colonoscopies, but to reach people who may otherwise skip screening.
  • FDA approved Shield in 2024 and it detects DNA fragments released by cancerous tumors.
  • The guidance notes Shield is best for those who can’t or won’t undergo colonoscopy or stool tests.
  • The test costs about $895 out of pocket and insurance coverage is not yet clear.
  • Experts say colonoscopy remains the most effective screening tool, with other tests offering additional options.
  • Cologuard and ColoSense are stool-based tests suggested as alternatives or complements to colonoscopy.
  • The American Cancer Society emphasizes screening uptake and early detection across age groups.
  • The guidance notes there is no data yet showing whether the Shield test saves lives in the long run.
  • Colorectal cancer remains a leading cause of death among younger adults, underscoring the value of varied screening options.
Vote 1
0
#2
3 new low-cost ways to check for colon cancer — that only take 5 minutes
#2 out of 299.69%
health1h ago

3 new low-cost ways to check for colon cancer — that only take 5 minutes

  • ACS expands screening options with a blood test and two home stool tests to detect colon cancer.
  • Cologuard Plus and ColoSense improve stool-based detection by looking for tumor DNA and other markers.
  • A new blood test, Shield, screens for cancer DNA in the blood and is FDA-approved.
  • Experts say stool and blood tests are more convenient but not a complete substitute for colonoscopy.
  • ACS notes screening uptake remains low among adults 45–49 despite rising colorectal cancer cases in younger people.
  • Screening tests require follow-up colonoscopy if results are positive.
  • Colorectal cancer screening remains linked to higher detection of cancers and polyps.
  • Insurance coverage varies; Shield and Cologuard Plus are Medicare-covered, while ColoSense is under review.
  • ACS emphasizes the best test is the one a patient will actually take.
  • The ACS recommendations aim to boost regular screening among adults 45–75.
  • Cologuard, ColoSense, and Shield are each presented as alternatives with varying sensitivity.
Vote 0
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement